Showing results (1621-1630 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|February 17, 2026
Pulse wave analysis for quality-of-life associated early physiological changes during breast cancer chemotherapy: A proof-of-concept pilot studyChao-Tsung Chen, Ruo-Ning Yu, Ting-Wei Yeh, et al.The Oncologist|February 3, 2026
Clinical outcomes of Lutetium-177-PSMA-617 in a racially diverse cohort of patients with metastatic castration-resistant prostate cancerMargo Brooke Gerke, Akshay Bedmutha, Angelo Marra, et al.The Oncologist|February 15, 2026
Second-line treatments for patients with PD1-refractory cutaneous squamous cell carcinomas: a brief reportHisham AlSharif, Veronika Danchine, Kira Deekollu, et al.The Oncologist|January 22, 2026
Age and sex as risk factors for health-related quality of life outcomes in patients with glioma: a CODAGLIO 2.0 analysisOgechukwu A Asogwa, Linda Dirven, Neil K Aaronson, et al.The Oncologist|January 17, 2026
Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM studyXubiao Wei, Yabo Jiang, Yong Li, et al.The Oncologist|January 17, 2026
An FDA analysis of the association of tumor growth rate, overall survival and progression-free survival in patients with metastatic NSCLCJustin N Malinou, Jiaxin Fan, Joyce Cheng, et al.The Oncologist|March 29, 2025
Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinomaJoel Randolph Hecht, Arjun Oberoi, Elena Garralda Cabanas, et al.The Oncologist|March 24, 2025
Emerging molecular testing paradigms in non-small cell lung cancer management-current perspectives and recommendationsFrédérique Penault-Llorca, Mark A SocinskiThe Oncologist|October 8, 2003
PET scans in the staging of lymphoma: current statusJonathan W Friedberg, Vaseem ChengaziPageof 571